Malignant Meningioma: rarity to creativity

Slides:



Advertisements
Similar presentations
Thoracic Surgery Innovations
Advertisements

Case 20 Thomas J. Giordano, M.D., Ph.D.. History A 54-year old man with a past medical history of goiter for approximately 4 years was followed by ultrasound.
IN THE NAME OF GOD. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy The American Journal.
CARBON ION THERAPY FOR SACRAL CHORDOMAS
We have listened to people who use ‘Good Medical Practice’ in their work - doctors in practice, NHS managers, patient representative groups and others.
Do you know what ’ s in people ’ s head?. Brain tumors 72 male 72 male HPI: presents to E.R. with history of confusion, change of personality, left sided.
Chubaka Producciones Presenta :.
2012 JANUARY Sun Mon Tue Wed Thu Fri Sat
P Pathophysiology Calendar. SundayMondayTuesdayWednesdayThursdayFridaySaturday January 2012.
Management of Ependymomas George Jallo Division of Pediatric Neurosurgery Johns Hopkins University.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Thomas F. DeLaney MD, Aashish D. Bhatt MD, Alex Jacobson BS, Richard Y. Lee MD, PhD, Christine Giraud BS, Joseph H. Schwab MD, MS, Francis J. Hornicek.
Management of Meningiomas. DIAGNOSTIC TOOLS MRI –Dural tail, edema CT SCAN:CT SCAN –Hyperostosis, intratumoral calcifications ANGIOGRAPHY: –embolization.
Meningiomas ( Benign, Atypical and Malignant or Anaplastic) By: By: Marquis Sparrow Marquis Sparrow.
The role of surgery in the management of mesothelioma Mr Martyn Carr Consultant Thoracic Surgeon Liverpool Heart and Chest Hospital.
Clinico-Pathological Conference (CPC) Meet Karpagam Medical College Hospital
Pneumonectomy for Locally Advanced Lung Cancer after Neoadjuvant Concurrent Chemo-radiation Therapy K. Okabe, H. Tao, T. Tanaka, T. Hayashi, K. Yoshiyama,
Long-term follow-up of a prospective trial of pre-operative external-beam radiation and post-operative brachytherapy for retroperitoneal sarcoma LA Mikula,
Transcranial orbital exenteration: An extended approach for intraorbital malignancies Lip Teh Matthew Hansen Royal Perth Hospital.
Power of science implemented in life quality Improvement of the effectiveness of radiation therapy with radiomodification by Polyplatillen and Fluoropyrimidine.
Neurology Case Conference 4 PROGNOSIS. Mortality and Morbidity Some patients die with meningioma and not from it Meningiomas usually grow slowly, and.
NYU Medical Grand Rounds Clinical Vignette Rachel Shur PGY-2 October 16, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
WORD JUMBLE. Months of the year Word in jumbled form e r r f b u y a Word in jumbled form e r r f b u y a february Click for the answer Next Question.
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl,
DATE POWER 2 INCOME JANUARY 100member X 25.00P2, FEBRUARY 200member X 25.00P5, MARCH 400member X 25.00P10, APRIL 800member.
2011 Calendar Important Dates/Events/Homework. SunSatFriThursWedTuesMon January
SunSatFriThursWedTuesMon January
Aggressive meningioma Robert M. Koffie Neurosurgery sub-intern July 19, 2012 Department of Neurosurgery Massachusetts General Hospital Harvard Medical.
A.Bocchio A.Bocchio Regional Hospital Valle d’Aosta, Italy Pilocytic juvenile astrocytoma: a difficult diagnosis?
©2011 MFMER | slide-1 AANP 2011 CASE #10 Mark Jentoft MD Nancy Kois MD Bernd Scheithauer MD.
Radical vs Partial Nephrectomy for treatment of renal cell carcinoma at Prince Hussein Urology Centre Dr. Mohammad Alserhan Urology specialist Prince Hussein.
July 2007 SundayMondayTuesdayWednesdayThursdayFridaySaturday
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
Experiences of Chi-Mei medical center in Taiwan Shin-Huei Huang (Kathy) Chun-Chia Chen, Yu-San Lin, Kuo-Feng Huang, Haw-Yen Chiu Nothing to disclose.
1 st Pyongyang International Neurosurgery Symposium, DPRK October, 2015 Marco Lee MD PhD FRCS Associate Professor Dept. of Neurosurgery Stanford.
Salvage Nipple-Sparing Mastectomy and Immediate Breast Reconstruction after Previous Breast Conservation Therapy: Same Safety, Better Cosmesis Che-Hsiung.
ADVERSE PROGNOSTIC FACTORS IMPACTING SURVIVAL IN RESECTED INVASIVE, MUCINOUS CYSTADENOCARCINOMAS OF THE PANCREAS Stephen J. Ko 1, Michele M. Corsini 2,
Primary sarcomas of the spine. A 5-year retrospective analysis. Hadjigeorgiou GF, Zisakis A, Markogiannakis G, Petrosyan T, Mylonakis I, Panteli A, Hadjigeorgiou.
SQUAMOUS CELL CARCINOMA OF MIDDLE EAR A CASE REPORT DR.ALEENA REHMAN(JR 1) DR.SUSHIL GAUR(AP) DR.O N SINHA (HOD) SANTOSH MEDICAL COLLEGE.
Paranasal sinus cancer
Case 11/2011 B. Lach Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ont. CANADA Abbreviations used: B-brain, M-meningioma,
Sinonasal Tumours Otolaryngology Rhinology
Sphenoid Wing Meningiomas
Discussion & Conclusion Predictives of Meningioma Grading
Basile Pache, Antonia Digklia*, Nicolas Demartines, Maurice Matter.
Meningeal tumor pathology
Treatment strategy of intracranial hemangiopericytoma
Case Study 2 Harry Kellermier.
Dictation practice 2nd Form Ms. Micaela-Ms. Verónica.
Today Galaxy S II Galaxy S III Neo Galaxy S7 Active
McDonald’s Kalender 2009.
McDonald’s Kalender 2009.
Sarcoma Wound Complications
Management of Skull Base Metastases
اسامی طراح سوالات سوال 1 و 2 دکتر دانشور سوال 3 و 4 دکتر ابوالحسنی
McDonald’s Kalender 2009.
Protocol Summary National Wilms Tumor Study Group (NWTS)
McDonald’s calendar 2007.
Neoadjuvant Adjuvant Curative Palliative
February 2007 Note: Source:.
Sinonasal Tumours Otolaryngology Rhinology
CNS tumors PhD Tomasz Wiśniewski.
McDonald’s calendar 2007.
Habitat Changes and Fish Migration
2015 January February March April May June July August September
Proton Therapy for Thymic Malignancies: Multi-institutional Patterns-of-Care and Early Clinical Outcomes from the Proton Collaborative Group Registry &
Surgical resection of metachronous liver metastases
Habitat Changes and Fish Migration
Standardised follow-up
Presentation transcript:

Malignant Meningioma: rarity to creativity MGH Neurosurgery Grand Rounds August 23, 2012 Leonardo Aliaga University of Chicago

Complex history of multiple recurrent meningiomas JD, 53y/o RHM Complex history of multiple recurrent meningiomas 2008

2008 – initial resection at Umass Path – atypical meningioma (II) 2010 April – Proton beam therapy 2011 March – 2nd resection 4 meningiomas removed Radioactive iodine seeds placed Path – rhabdoid malignant meningioma (III) 2011 March, preop

Asdasd 2011 July 2011 October

Asdasd 2011 July 2011 October

2011 October 2012 February 2012 June 3rd resection

2012 June

August 2012, 4th resection Worsening left sided weakness Worsening eye pain, proptosis

August 2012, 4th resection Planned subtotal resection, sparing of eye Right frontal craniotomy - resection of 2 frontal parasagittal meningiomas Right orbitozygomatic osteotomy - resection of orbital sphenoid wing recurrence Planned subtotal resection, sparing of eye Exploration of infratemporal fossa

August 2012, 4th resection Planned subtotal resection, sparing of eye Right frontal craniotomy - resection of 2 frontal parasagittal meningiomas Right orbitozygomatic osteotomy - resection of orbital sphenoid wing recurrence Planned subtotal resection, sparing of eye Exploration of infratemporal fossa Plastic surgery – cranioplasty and scalp flap reconstruction

Post-op course

Post-op course Complicated by low hematocrit, tachycardia, confusion and delerium, downtrending Na Transfused, PE protocol CT negative, Na normalized Discharged on POD 8, LUE 3/5, LLE wiggled toes

What does the future hold Mr. JD?

Malignant Meningioma Meningiomas – 30% of CNS neoplasm Grade III – malignant meningioma, 1-3% 2007 WHO Criteria Papillary, rhabdoid and anaplastic histological subtypes 20 or more mitoses per HPF and/or malignant characteristics resembling carcinoma, sarcoma, or melanoma

Recurrence, Resection, Radiation

Recurrence, Resection, Radiation

Recurrence, Resection, Radiation

Recurrence, Resection, Radiation Marked survival benefit for 37 pts undergoing second resection for recurrence

Recurrence, Resection, Radiation 34 pts,undergoing primary operation 37 pts, undergoing second operation Minor survival benefit with subtotal resection vs. gross-total resection

Recurrence, Resection, Radiation

Recurrence, Resection, Radiation Radiation for recurrence 45 pts undergoing resection for recurrence 26 underwent at least 1 treatment of focal radiotherapy SRS Iodine-125 brachytherapy No difference in survival with focal radiotherapy after resection

Creativity and the future

Thank you MGH Department of Neurosurgery Harvard Medical School University of Chicago